CalciMedica, Inc. CALC
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2020-09-25
CalciMedica, Inc. statistics & valuation
Market cap$12.9M
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -217.5% | -69.2% | -282.0% | -233.6% | -51.8% |
| Return on equity | 445.1% | -95.1% | -421.2% | 11.0% | 56.0% |
| Current ratio | 3.58 | 5.34 | 2.88 | 0.36 | 16.53 |
Source: SEC EDGAR filings · CIK 0001534133 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.